Emerging therapeutic strategies are focused on targeting the trophoblast cell surface antigen 2 (TROP-2), a cell membrane glycoprotein receptor that plays a critical role in promoting tumor growth, proliferation, and metastasis by acting as a transmembrane transducer of intracellular calcium signaling [9]. Here, TACSTD2 is linked to neoplasm.